Survival Impact of Occult Metastases in NSABP B-32: Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Breast Cancer.

被引：0
|
作者：
Weaver, D. L.
Ashikaga, T.
Krag, D. N.
Skelly, J. M.
Anderson, S. J.
Harlow, S. P.
Julian, T. B.
Mamounas, E. P.
Wolmark, N.
机构：
[1] Univ Vermont, Coll Med, Burlington, VT 05405 USA
[2] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA
[3] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[4] Aultman Caner Ctr, Canton, OH USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
280
引用
下载
收藏
页码：69A / 69A
页数：1
相关论文
共 50 条
  • [1] Survival Impact of Occult Metastases in NSABP B-32: Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Breast Cancer
    Weaver, D. L.
    Ashikaga, T.
    Krag, D. N.
    Skelly, J. M.
    Anderson, S. J.
    Harlow, S. P.
    Julian, T. B.
    Mamounas, E. P.
    Wolmark, N.
    LABORATORY INVESTIGATION, 2011, 91 : 69A - 69A
  • [2] Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy
    Cox, C
    White, L
    Allred, N
    Meyers, M
    Dickson, D
    Dupont, E
    Cantor, A
    Ly, Q
    Dessureault, S
    King, J
    Nicosia, S
    Vrcel, V
    Diaz, N
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (05) : 708 - 711
  • [3] Survival Outcomes in Node-Negative Breast Cancer Patients Evaluated With Complete Axillary Node Dissection Versus Sentinel Lymph Node Biopsy
    Charles Cox
    Laura White
    Nathon Allred
    Michael Meyers
    Daniel Dickson
    Elisabeth Dupont
    Alan Cantor
    Quan Ly
    Sophie Dessureault
    Jeff King
    Santo Nicosia
    Vesna Vrcel
    Nils Diaz
    Annals of Surgical Oncology, 2006, 13 : 708 - 711
  • [4] Effect of axillary dissection for occult detected sentinel nodes metastases on survival: NSABP B-32
    Julian, T. B.
    Anderson, S. J.
    Mamounas, E. P.
    Krag, D. N.
    Weaver, D.
    Ashikaga, T.
    Harlow, S. P.
    Wolmark, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [5] Morbidity Results From the NSABP B-32 Trial Comparing Sentinel Lymph Node Dissection Versus Axillary Dissection
    Ashikaga, Takamaru
    Krag, David N.
    Land, Stephanie R.
    Julian, Thomas B.
    Anderson, Stewart J.
    Brown, Ann M.
    Skelly, Joan M.
    Harlow, Seth P.
    Weaver, Donald L.
    Mamounas, Eleftherios P.
    Costantino, Joseph P.
    Wolmark, Norman
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (02) : 111 - 118
  • [6] Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
    Krag, David N.
    Anderson, Stewart J.
    Julian, Thomas B.
    Brown, Ann M.
    Harlow, Seth P.
    Costantino, Joseph P.
    Ashikaga, Takamaru
    Weaver, Donald L.
    Mamounas, Eleftherios P.
    Jalovec, Lynne M.
    Frazier, Thomas G.
    Noyes, R. Dirk
    Robidoux, Andre
    Scarth, Hugh M. C.
    Wolmark, Norman
    LANCET ONCOLOGY, 2010, 11 (10): : 927 - 933
  • [7] Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection (CALND) versus sentinel lymph node (SLN) biopsy
    Cox, C
    Wilkie, C
    White, LB
    Allred, NC
    Meyers, MP
    Dickson, D
    Dupont, E
    Ly, Q
    Dessureault, S
    Diaz, N
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S68 - S68
  • [8] Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
    Bear, HD
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 1) : S7 - S7
  • [9] Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
    HD Bear
    Breast Cancer Research, 7
  • [10] Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
    Krag, David N.
    Anderson, Stewart J.
    Bjulian, Thomas
    Brown, Ann M.
    Harlow, Seth P.
    Ashikaga, Takamaru
    Weaver, Donald L.
    Miller, Barbara J.
    Jalovec, Lynne M.
    Frazier, Thomas G.
    Noyes, R. Dirk
    Robidoux, Andre
    Scarth, Hugh M. C.
    Mammolito, Denise M.
    McCready, David R.
    Mamounas, Eleftherios P.
    Costantino, Joseph P.
    Wolmark, Norman
    LANCET ONCOLOGY, 2007, 8 (10): : 881 - 888
12345